BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29488425)

  • 1. Amikacin-containing self-emulsifying delivery systems via pulmonary administration for treatment of bacterial infections of cystic fibrosis patients.
    Hetényi G; Griesser J; Fontana S; Gutierrez AM; Ellemunter H; Niedermayr K; Szabó P; Bernkop-Schnürch A
    Nanomedicine (Lond); 2018 Apr; 13(7):717-732. PubMed ID: 29488425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly mucus permeating and zeta potential changing self-emulsifying drug delivery systems: A potent gene delivery model for causal treatment of cystic fibrosis.
    Griesser J; Hetényi G; Federer C; Steinbring C; Ellemunter H; Niedermayr K; Bernkop-Schnürch A
    Int J Pharm; 2019 Feb; 557():124-134. PubMed ID: 30594687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imine bond formation as a tool for incorporation of amikacin in self-emulsifying drug delivery systems (SEDDS).
    Dizdarević A; Marić M; Shahzadi I; Ari Efiana N; Matuszczak B; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2021 May; 162():82-91. PubMed ID: 33737147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of self-emulsifying drug delivery systems (SEDDS) for ciprofloxacin with improved mucus permeating properties.
    Zaichik S; Steinbring C; Menzel C; Knabl L; Orth-Höller D; Ellemunter H; Niedermayr K; Bernkop-Schnürch A
    Int J Pharm; 2018 Aug; 547(1-2):282-290. PubMed ID: 29883790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, in vitro and in vivo evaluation of a self-emulsifying drug delivery system (SEDDS) for oral enoxaparin administration.
    Zupančič O; Grieβinger JA; Rohrer J; Pereira de Sousa I; Danninger L; Partenhauser A; Sündermann NE; Laffleur F; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2016 Dec; 109():113-121. PubMed ID: 27693677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypsin decorated self-emulsifying drug delivery systems (SEDDS): Key to enhanced mucus permeation.
    Shahzadi I; Dizdarević A; Efiana NA; Matuszczak B; Bernkop-Schnürch A
    J Colloid Interface Sci; 2018 Dec; 531():253-260. PubMed ID: 30036849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Intestinal Mucus Permeation of Vancomycin via Incorporation Into Nanocarrier Containing Papain-Palmitate.
    Efiana NA; Dizdarević A; Huck CW; Bernkop-Schnürch A
    J Pharm Sci; 2019 Oct; 108(10):3329-3339. PubMed ID: 31136766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and in vitro characterization of a papain loaded mucolytic self-emulsifying drug delivery system (SEDDS).
    Leichner C; Menzel C; Laffleur F; Bernkop-Schnürch A
    Int J Pharm; 2017 Sep; 530(1-2):346-353. PubMed ID: 28782582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zeta potential changing self-emulsifying drug delivery systems: A promising strategy to sequentially overcome mucus and epithelial barrier.
    Nazir I; Fürst A; Lupo N; Hupfauf A; Gust R; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2019 Nov; 144():40-49. PubMed ID: 31505225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-emulsifying drug delivery systems: Design of a novel vaginal delivery system for curcumin.
    Köllner S; Nardin I; Markt R; Griesser J; Prüfert F; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2017 Jun; 115():268-275. PubMed ID: 28323109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and in vitro characterization of self-emulsifying drug delivery system (SEDDS) for oral opioid peptide delivery.
    Zupančič O; Rohrer J; Thanh Lam H; Grießinger JA; Bernkop-Schnürch A
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1694-1702. PubMed ID: 28589736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of SEDDS and Preactivated Thiomer Technology: Incorporation of a Preactivated Thiolated Amphiphilic Polymer into Self-Emulsifying Delivery Systems.
    Hetényi G; Griesser J; Nardin I; Bernkop-Schnürch A
    Pharm Res; 2017 Jun; 34(6):1171-1179. PubMed ID: 28283859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucolytic self-emulsifying drug delivery systems (SEDDS) containing a hydrophobic ion-pair of proteinase.
    Lam HT; Le NN; Phan TNQ; Bernkop-Schnürch A
    Eur J Pharm Sci; 2021 Jul; 162():105658. PubMed ID: 33271277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-emulsifying peptide drug delivery systems: How to make them highly mucus permeating.
    Griesser J; Hetényi G; Kadas H; Demarne F; Jannin V; Bernkop-Schnürch A
    Int J Pharm; 2018 Mar; 538(1-2):159-166. PubMed ID: 29339247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and in vitro evaluation of a self-emulsifying drug delivery system (SEDDS) for oral vancomycin administration.
    Zaichik S; Steinbring C; Caliskan C; Bernkop-Schnürch A
    Int J Pharm; 2019 Jan; 554():125-133. PubMed ID: 30408530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin.
    Ehsan Z; Clancy JP
    Future Microbiol; 2015; 10(12):1901-12. PubMed ID: 26573178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin-loaded lipid-core nanocapsules as mucus penetrating drug delivery system intended for the treatment of bacterial infections in cystic fibrosis.
    Torge A; Wagner S; Chaves PS; Oliveira EG; Guterres SS; Pohlmann AR; Titz A; Schneider M; Beck RCR
    Int J Pharm; 2017 Jul; 527(1-2):92-102. PubMed ID: 28499793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and in vitro evaluation of zeta potential changing self-emulsifying drug delivery systems for enhanced mucus permeation.
    Suchaoin W; Pereira de Sousa I; Netsomboon K; Lam HT; Laffleur F; Bernkop-Schnürch A
    Int J Pharm; 2016 Aug; 510(1):255-62. PubMed ID: 27329673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and in vitro characterization of an oral self-emulsifying delivery system (SEDDS) for rutin fatty ester with high mucus permeating properties.
    Cardona MI; Nguyen Le NM; Zaichik S; Aragón DM; Bernkop-Schnürch A
    Int J Pharm; 2019 May; 562():180-186. PubMed ID: 30898639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zeta potential changing self-emulsifying drug delivery systems containing phosphorylated polysaccharides.
    Griesser J; Burtscher S; Köllner S; Nardin I; Prüfert F; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2017 Oct; 119():264-270. PubMed ID: 28684278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.